Ciprofloxacin Market: By Dosage form (Powder, Suspension, Tablet, Eye drops, Intravenous preparation), By Application (Urinary Tract Infections, Lower Respiratory Infections, Nosocomial Pneumonia, Skin Structure Infections, Bone and Joint Infections, Intra-Abdominal Infection, Acute Sinusitis, Chronic Bacterial Prostatitis), By Distribution channel (Hospitals Pharmacies, Retail pharmacies, Drug stores, Online pharmacies) and Geography

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Ciprofloxacin Market Size was valued at USD x million in 2022 and is poised to grow at a 6.9% CAGR from 2023 to 2029. Ciprofloxacin is one of the broad-spectrum antibiotics for the drug class quinolone antibiotic. To maintain the antibiotic's effectiveness, the antibiotic Ciprofloxacin is largely employed to stop the growth of bacteriophages that are resistant to it. Only bacterial illnesses are treated with the medication ciprofloxacin; viral infections are not affected by it. The Urinary Tract Infections segment anticipated to grow at significant CAGR over the forecast years owing to Due to differences in anatomy, women are more likely than men to get urinary tract infections. In their lifetimes, many women get urinary tract infections more than once. According to some research, there are 150 million cases of urinary tract infections worldwide. Additionally, about 11% of women see a doctor for treatment of a UTI once a year. Moreover, competitors are focusing on launching and acquisition to maintain growth in the market. For instance, In December 2002 FDA Approves Once-Daily Cipro XR for the Treatment of Uncomplicated Urinary Tract Infections (UTIs). Increase in prevalence of bacterial infection such as (UTI), eye infections, among others is anticipated to create lucrative growth opportunities for the ciprofloxacin market.

Ciprofloxacin Market Summary

Study Period

2023-29

Base Year

2022

CAGR

6.9%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Ciprofloxacin Market Dynamics

The incidence of kidney infections and eye infections is one of the main factors propelling the Ciprofloxacin market's expansion. due to higher efficacy of Ciprofloxacin in treating the infections associated with the excretory system especially renal and urinary system. In June 2018 the US FDA warned the manufacturers and issued guidelines for the labeling black box warning mentioning safety warnings for the fluoroquinolones category of medicines. Considering the drug's negative effects on tendons and skin in paediatric and geriatric patients. It is projected that there would be a significant increase in demand for ciprofloxacin because of the requirement for broad spectrum antibiotics in the global pharmaceutical market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Ciprofloxacin Market Segmentation

By Dosage Form
  • Powder
  • Suspension
  • Tablet
  • Eye drops
  • Intravenous preparation
By Application
  • Urinary Tract Infections
  • Lower Respiratory Infections
  • Nosocomial Pneumonia
  • Skin Structure Infections
  • Bone and Joint Infections
  • Intra-Abdominal Infection
  • Acute Sinusitis
  • Chronic Bacterial Prostatitis
By Distribution Channel
  • Hospitals Pharmacies
  • Retail pharmacies
  • Drug stores
  • Online pharmacies
By Geography
  • North America
  • Europe
  • The Asia Pacific
  • Latin America
  • MEA

Frequently Asked Questions

2022 is the base year and 2029 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

  • Novartis International AG
  • Allergan plc
  • Merck & Co Inc
  • Cipla Limited
  • Bayer AG
  • Cadila Healthcare
  • Glenmark Pharmaceuticals
  • Hexal
  • Sanofi Synthelabo
  • Pfleger
  • Mylan Laboratories Ltd